🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Non-Active Secondary Progressive Multiple Sclerosis

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis NCT06890923Phase 21 site📍 Boston Tiziana Life Sciences LTD · Tests: Foralumab TZLS-401 100 µg Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). NCT05961644Phase 2, Phase 31 site📍 Warsaw Institute of Psychiatry and Neurology, Warsaw · Tests: Cladribine Subcutaneous Injection, 0.9% Chloride Injection Sodium A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS) NCT07840326Phase 23 sites📍 Atlanta📍 Raleigh📍 Columbus Sundance Biosciences, Inc. · Tests: SUN-627, Placebo A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis NCT07299019Phase 361 sites📍 Phoenix📍 Scottsdale📍 Fullerton Zenas BioPharma (USA), LLC · Tests: Orelabrutinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy